https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-05-27T20:14:32.297Z NovaPharmaNews en-AU 2026-05-27T04:39:16.935Z Regulatory Round-Up: Drug Approvals on 26 May 2026 https://novapharmanews.com/uploads/articles/regulatory-round-up-drug-approvals-26-may-2026.webp Regulatory Round-Up: Drug Approvals on 26 May 2026 https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-05-27T19:43:13.966Z NovaPharmaNews en-US 2026-05-27T04:39:09.399Z FDA vs EMA: The Camizestrant Controversy Camizestrant, oncology https://novapharmanews.com/uploads/articles/fda-vs-ema-camizestrant-controversy.webp FDA vs EMA: The Camizestrant Controversy https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-05-27T14:08:38.130Z NovaPharmaNews en-US 2026-05-27T04:39:09.399Z Top Biotech Stocks to Watch in May 2026: Clinical Trials Insights https://novapharmanews.com/uploads/articles/best-biotech-stocks-may-2026-clinical-trials.webp Top Biotech Stocks to Watch in May 2026: Clinical Trials Insights https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-05-27T15:06:07.596Z NovaPharmaNews en-GB 2026-05-27T04:39:09.399Z The Critical Medicines Act: Transforming Pharma Manufacturing in Europe https://novapharmanews.com/uploads/articles/critical-medicines-act-impact-pharmaceutical-manufacturing-europe.webp The Critical Medicines Act: Transforming Pharma Manufacturing in Europe https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-05-27T15:06:06.957Z NovaPharmaNews en-GB 2026-05-27T04:39:09.399Z Arrowhead Pharmaceuticals Unveils Positive Cardiometabolic Data at European A cardiometabolic disorders https://novapharmanews.com/uploads/articles/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a.webp Arrowhead Pharmaceuticals Unveils Positive Cardiometabolic Data at European A https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-05-27T15:06:09.037Z NovaPharmaNews en-GB 2026-05-27T04:39:09.399Z MaaT Pharma Q1 2026 Business Update and Financial Results https://novapharmanews.com/uploads/articles/maat-pharma-q1-2026-business-update.webp MaaT Pharma Q1 2026 Business Update and Financial Results https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-05-27T20:17:17.575Z NovaPharmaNews en-AU 2026-05-27T04:39:09.399Z Lundbeck Secures Korean Approval for Vyepti: Implications for Oncology and Migraine Treatment Vyepti, oncology, migraine https://novapharmanews.com/uploads/articles/lundbeck-korean-approval-vyepti-oncology-migraine.webp Lundbeck Secures Korean Approval for Vyepti: Implications for Oncology and Migraine Treatment https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-05-27T20:16:05.966Z NovaPharmaNews en-AU 2026-05-27T04:39:09.399Z Bukwang Pharmaceutical Partners with DreamCIS and AWS for Clinical Trials https://novapharmanews.com/uploads/articles/bukwang-pharmaceutical-dreamcis-aws-clinical-trials.webp Bukwang Pharmaceutical Partners with DreamCIS and AWS for Clinical Trials https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-05-27T12:42:20.368Z NovaPharmaNews en-US 2026-05-27T04:39:09.399Z Astellas Faces Xtandi Patent Cliff: Strategic Moves Ahead Xtandi https://novapharmanews.com/uploads/articles/astellas-xtandi-patent-cliff-strategic-moves.webp Astellas Faces Xtandi Patent Cliff: Strategic Moves Ahead https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-05-27T19:21:45.633Z NovaPharmaNews en-AU 2026-05-27T04:39:09.399Z 60 Degrees Pharmaceuticals Initiates Clinical Trial for Tafenoquine in Babesiosis Patients Tafenoquine, Babesiosis https://novapharmanews.com/uploads/articles/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis.webp 60 Degrees Pharmaceuticals Initiates Clinical Trial for Tafenoquine in Babesiosis Patients https://novapharmanews.com/eu/news/esmo-breast-cancer-congress-2026-highlights 2026-05-27T15:06:08.434Z NovaPharmaNews en-GB 2026-05-26T10:17:57.034Z ESMO Breast Cancer Congress 2026: Key Insights for Investors oncology, breast cancer https://novapharmanews.com/uploads/articles/esmo-breast-cancer-congress-2026-highlights.webp ESMO Breast Cancer Congress 2026: Key Insights for Investors https://novapharmanews.com/us/news/fda-new-form-483-response-guidance 2026-05-27T08:11:51.566Z NovaPharmaNews en-US 2026-05-26T10:17:57.034Z FDA's New Form 483 Response Guidance: Implications for Pharma https://novapharmanews.com/uploads/articles/fda-new-form-483-response-guidance.webp FDA's New Form 483 Response Guidance: Implications for Pharma